# A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response.

> **NCT07191587** · NA · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 146 (actual)

## Conditions studied

- Peripheral Neuropathy, Chemotherapy-induced
- Disease Management

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin B Complex

## Key facts

- **NCT ID:** NCT07191587
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07191587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07191587, "A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07191587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*